Go Pro
OTCMKTS:DYXC

DiaSys (DYXC) Stock Price, News & Analysis

About DiaSys Stock (OTCMKTS:DYXC)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

DiaSys Diagnostic Systems GmbH, trading as OTCMKTS:DYXC, is a global developer, manufacturer and distributor of in vitro diagnostic reagents and systems. The company specializes in clinical chemistry and point-of-care testing solutions, providing a comprehensive portfolio of reagents for routine clinical parameters, specialty protein assays and electrolytes. It also supplies calibration and quality control materials designed to ensure the accuracy and reliability of laboratory results.

DiaSys offers a broad range of diagnostic products, including ready-to-use reagent kits, lyophilized reagents and automated test panels compatible with a variety of bench-top and high-throughput analyzers. The company supports clinical laboratories, hospitals and point-of-care settings with technical services, instrument support and customized assay development. Its product lineup encompasses assays for cardiology markers, diabetes management, therapeutic drug monitoring and general chemistry analyses.

Headquartered in Holzheim, Germany, DiaSys serves a global customer base through direct subsidiaries and distributor partnerships across Europe, the Middle East, Africa, Asia and Latin America. With a strong emphasis on research and development, the company focuses on advancing diagnostic capabilities by introducing innovative assay formats and expanding its reagent portfolio. DiaSys’s management team brings extensive experience in clinical diagnostics and life-science industries, guiding strategic growth in both emerging markets and established territories.

AI Generated. May Contain Errors.

Receive DYXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DiaSys and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DYXC Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

DYXC Stock Analysis - Frequently Asked Questions

Shares of DYXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/22/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:DYXC
CIK
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:DYXC) was last updated on 8/22/2026 by MarketBeat.com Staff.
From Our Partners